Express Scripts, Urban Outfitters: S&P Gainers
The S&P 500 dropped 5.73 points, or 0.4%, to close at 1413.
Shares of Express Scripts increased 2.38% to $57.67. Bloomberg reported Tuesday that a hearing will be held on April 10 regarding a private antitrust lawsuit seeking to stop the company's combination with Medco Health Solutions(MHS) , a deal which was approval by the Federal Trade Commission on Monday.
Express Scripts' shares trade at an estimated price-to-earnings ratio for next year of 13.27X; the average for health care providers is 15.63X. For comparison, both WellPoint(WLP) and Aetna(AET) have lower forward P/Es of 8.55X and 8.84X.
Twenty-four of the 27 analysts who cover Express Scripts rate it at buy; three analysts give the stock a hold rating.
TheStreet Ratings gives Express Scripts a B grade with a buy rating and $61.40 price target. The stock has risen 29.04% year to date.